Detalhe da pesquisa
1.
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
Am J Hematol
; 99(4): 741-744, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279562
2.
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.
Blood
; 138(21): 2142-2148, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945619
3.
Solid organ transplant recipients during COVID-19 pandemic.
Am J Transplant
; 20(10): 2960-2961, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515045
4.
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.
Leukemia
; 38(2): 326-339, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148396
5.
Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype.
Clin Lymphoma Myeloma Leuk
; 22(3): e199-e205, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674982
6.
Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines.
Clin Lymphoma Myeloma Leuk
; 20(2): e76-e81, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31865004
7.
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID).
Leukemia
; 37(8): 1741-1744, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433887